Barclays »

Rapt Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $79k 40k 1.99
2024-06-30 $31k 11k 2.96
2024-03-31 $830k 93k 8.96
2023-12-31 $1.9M 79k 24.84
2023-09-30 $892k 54k 16.63
2023-06-30 $1.2M 64k 18.70
2023-03-31 $917k 50k 18.33
2022-12-31 $1.6M 80k 19.80
2022-09-30 $1.1M 45k 24.08
2022-06-30 $48k 2.6k 18.38
2022-03-31 $580k 26k 21.98